Efficacy of Everolimus Combined With First-line Endocrine Therapy for HR+/HER2- SNF1-subtype Advanced Breast Cancer
Clinical trial NCT05949541 · RECRUITING
Trial details
- NCT number
- NCT05949541
- Sponsor
- Fudan University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-26
- Primary completion
- 2026-07-01
- Enrollment
- 265
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.